Contribution of Common and Rare Variants to Bipolar Disorder Susceptibility in Extended Pedigrees from Population Isolates

Jae Hoon Sul,Susan K. Service,Alden Y. Huang,Vasily Ramensky,Sun-Goo Hwang,Terri M. Teshiba,YoungJun Park,Anil P. S. Ori,Zhongyang Zhang,Niamh Mullins,Loes M. Olde Loohuis,Scott C. Fears,Carmen Araya,Xinia Araya,Mitzi Spesny,Julio Bejarano,Margarita Ramirez,Gabriel Castrillón,Juliana Gomez-Makhinson,Maria C. Lopez,Gabriel Montoya,Claudia P. Montoya,Ileana Aldana,Javier I. Escobar,Jorge Ospina-Duque,Barbara Kremeyer,Gabriel Bedoya,Andres Ruiz-Linares,Rita M. Cantor,Julio Molina,Giovanni Coppola,Roel A. Ophoff,Gabriel Macaya,Carlos Lopez-Jaramillo,Victor Reus,Carrie E. Bearden,Chiara Sabatti,Nelson B. Freimer
DOI: https://doi.org/10.1038/s41398-020-0758-1
2020-01-01
Translational Psychiatry
Abstract:Current evidence from case/control studies indicates that genetic risk for psychiatric disorders derives primarily from numerous common variants, each with a small phenotypic impact. The literature describing apparent segregation of bipolar disorder (BP) in numerous multigenerational pedigrees suggests that, in such families, large-effect inherited variants might play a greater role. To identify roles of rare and common variants on BP, we conducted genetic analyses in 26 Colombia and Costa Rica pedigrees ascertained for bipolar disorder 1 (BP1), the most severe and heritable form of BP. In these pedigrees, we performed microarray SNP genotyping of 838 individuals and high-coverage whole-genome sequencing of 449 individuals. We compared polygenic risk scores (PRS), estimated using the latest BP1 genome-wide association study (GWAS) summary statistics, between BP1 individuals and related controls. We also evaluated whether BP1 individuals had a higher burden of rare deleterious single-nucleotide variants (SNVs) and rare copy number variants (CNVs) in a set of genes related to BP1. We found that compared with unaffected relatives, BP1 individuals had higher PRS estimated from BP1 GWAS statistics ( P = 0.001 ~ 0.007) and displayed modest increase in burdens of rare deleterious SNVs ( P = 0.047) and rare CNVs ( P = 0.002 ~ 0.033) in genes related to BP1. We did not observe rare variants segregating in the pedigrees. These results suggest that small-to-moderate effect rare and common variants are more likely to contribute to BP1 risk in these extended pedigrees than a few large-effect rare variants.
What problem does this paper attempt to address?